Regavirumab

DB33794ExperimentalProtein Based Therapies

Regavirumab: Overview.

Code names
MCA-C23 ยท TI-23

Resolves to

Compound
UNIISTG2Q92FWFChEMBLCHEMBL2107880

Which companies are running trials of Regavirumab, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In